We are international
Donate
• IMF TV TEXT SIZE   
#Ask Dr. Durie

ask_dr_durie_banner

 

Have a question? Submit it to AskDrDurie@myeloma.org!
 

facebook
googleplus
twitter
youtube


IMF Chairman and Co-Founder Brian G.M. Durie, MD welcomes your questions about the latest myeloma treatments, research, controversies and quality of life issues. If you have a question you think might be of interest to the myeloma community, please send to askdrdurie@myeloma.org! For questions of a specific personal nature, please call the IMF InfoLine coordinators at 800.452.2873 or email them at infoline@myeloma.org.

Our archives are brimming with useful information directed at - and asked by - patients, caregivers, and other interested parties... so please watch the episodes below, and share them as much as possible so that others may benefit!


 

 

 

#Ask Dr. Durie
    next      view all

05.27.15   Is the combination of Kyprolis, Cytoxan and dexamethasone available as a treatment?

In this week's video, Dr. Brian Durie answers a patient's question if the combination of Kyprolis, Cytoxan, and dexamethasone is available as a treatment.


05.21.15   Are veterans with myeloma a unique population?

In this week's video, Dr. Brian Durie answers the question "Are veterans with myeloma a unique population?" Dr. Durie also talked about the challenges that veterans face to get the best care available to them. For more information about veterans with myeloma you can visit: www.veterans.myeloma.org .


05.13.15   How does myeloma affect the immune system?

In this week's video, Dr. Brian Durie discusses how does myeloma affect the immune system and what can be done for the iHommune system to work better.


05.07.15   What is IVIG?

In this week's #AskDrDurie video, IMF Chairman Dr. Brian Durie discusses how Intravenous Immunogloblin is being used as a treatment option for multiple myeloma.


04.30.15   Is chiropractic care an option for patients with myeloma?

In this episode of #AskDrDurie, IMF Chairman Dr. Brian Durie discusses the risks that can come with chiropractic care for patients with myeloma. He also offers some alternative therapeutic options for those who need them.


04.23.15   Does pomalidomide work on a myeloma patient that has not had a response with other iMiDs?

In this episode of #AskDrDurie, IMF Chairman Dr. Brian Durie discusses the success a myeloma patient can have with pomalidomide, even if that patient has not had a response with other drugs in the iMiD category.


04.16.15   When will the first monoclonal antibody be approved?

In this episode of #AskDrDurie, IMF Chairman Dr. Brian Durie discusses the progress being made with monoclonal antibodies being used to treat myeloma. He highlights three specific ones (daratumumab, Sanofi’s SAR compound, and elotuzumab) and discusses why each is promising.


04.09.15   If stringent complete remission is achieved, is maintenance therapy still required?

In this episode of #AskDrDurie, IMF Chairman Dr. Brian Durie offers his take on whether or not maintenance is recommended for a patient who has already achieved a stringent complete remission (SCR) with his or her myeloma.


04.02.15   What are myeloma treatment options for a patient with bipolar disorder?

In this week’s episode of #AskDrDurie, IMF Chairman Dr. Brian Durie looks at the factors of myeloma that affect the choice of treatment, including the type of myeloma and any chromosome abnormalities, as well as genetic testing done on the patient.


03.26.15   Does the type of myeloma impact the choice of treatment?

In this week’s episode of #AskDrDurie, IMF Chairman Dr. Brian Durie looks at the factors of myeloma that affect the choice of treatment, including the type of myeloma and any chromosome abnormalities, as well as genetic testing done on the patient.


    next      view all